427 related articles for article (PubMed ID: 25981400)
1. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
4. Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells.
Umekawa T; Byer K; Uemura H; Khan SR
Nephrol Dial Transplant; 2005 May; 20(5):870-8. PubMed ID: 15755756
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone induces superoxide generation via Rac1 activation in endothelial cells.
Iwashima F; Yoshimoto T; Minami I; Sakurada M; Hirono Y; Hirata Y
Endocrinology; 2008 Mar; 149(3):1009-14. PubMed ID: 18079208
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
7. Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study.
Joshi S; Saylor BT; Wang W; Peck AB; Khan SR
PLoS One; 2012; 7(10):e47738. PubMed ID: 23091645
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
9. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
[TBL] [Abstract][Full Text] [Related]
10. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
[TBL] [Abstract][Full Text] [Related]
11. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.
Zuo J; Khan A; Glenton PA; Khan SR
Nephrol Dial Transplant; 2011 Jun; 26(6):1785-96. PubMed ID: 21378157
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and aldosterone activate retinal microglia.
Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
[TBL] [Abstract][Full Text] [Related]
14. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
16. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells.
Masamune A; Watanabe T; Kikuta K; Satoh K; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G99-G108. PubMed ID: 17962358
[TBL] [Abstract][Full Text] [Related]
18. Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.
Leung JC; Chan LY; Tang SC; Lam MF; Chow CW; Lim AI; Lai KN
J Transl Med; 2011 Oct; 9():169. PubMed ID: 21974877
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells.
Rajamohan SB; Raghuraman G; Prabhakar NR; Kumar GK
Antioxid Redox Signal; 2012 Aug; 17(3):445-59. PubMed ID: 22214405
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
